Study Background
Oral agents for chemotherapy are becoming an increasingly common modality for treatment
Patients receiving these treatments experience variable adherence, high symptom burden, yet have limited contacted with their providers compared to patients receiving chemotherapy infusions.
​
Twelve (12) NCORP community oncology sites, both rural and urban, will be recruited and cluster randomized. Community sites will participate for two years and will recruit 43 patients receiving oral chemotherapy.
Study Design
CC012CD is a cluster-randomized trial where twelve eligible NCORP community sites will be recruited. Six (6) practices will be randomized to the ATSM+TIPC intervention, and six (6) practices will be randomized to an active control (IVR only).
​
Practices will be asked to identify at minimum one (1) staff members who will be consented to participate in the study as clinic personnel. A total of 43 participants will be enrolled at each community site. For patients to be eligible to participate, they must be initiating treatment with an oral chemotherapy agent.
Intervention: ATSM+TIPC
Participants at these community sites will receive Interactive Voice Response (IVR) telephone symptom monitoring plus referral to self-management strategies provided via a printed handbook (ATSM). Any participants who report unresolved psychological distress in the first four (4) weeks will also receive Telephone Interpersonal Counselling (TIPC) for 8 weeks. Symptom reports from the IVR system will be sent to clinic personnel.
​
Active Control: IVR only
Participants at these community sites will receive Interactive Voice Response (IVR) telephone symptom monitoring only for 12 weeks. Symptom reports from the ATSM system will be sent to clinic personnel.
Community Site Work Flow
Community Site Eligibility and Participation
If you are interested in opening this trial at your NCORP community site, please see all study documents in CTSU. Contact us to learn more!
Site Training Materials
Winter NRG 2024 Site Training
Summer NRG 2024 Updated Site Training
Monthly Study Updates
September 2024 Study Update
October 2024 Study Update
Study Chairs and Team
Stephanie Pugh, PhD, Statistician, NRG Stats and Data Management
Vamsi Vasireddy, DO, NCORP Community Chair, Carle Cancer Institute
Melyssa Foust, MSN, RN,
Nursing Co-Chair, Upstate Carolina NCORP
Jamillah Gross-Caldwell,
Study Coordinator - Michigan State University
​​
Grey Freylersythe,
Study Coordinator - University of Miami
​​
Ready to Learn More?
Contact Us!
SYMON@miami.edu
(305) 243-9832